Security Investigation
The Chemours Company (NYSE: CC)
56 Days left to seek lead plaintiff status.
Contact a Lawyer Now
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until December 7, 2026 to file lead plaintiff applications in a securities class action lawsuit against The Chemours Company (“Chemours” or the “Company”) (NYSE: CC).
Chemours and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
On August 4, 2026, post-market, the Company announced its 2Q 2026 financial results and cut its full-year adjusted EBITDA guidance to $775–$825 million, down from $800–$900 million. On the earnings call the next morning, CEO Denise Dignam admitted that “[a]s a result of the initial channel fill, aftermarket customers built additional inventory, creating an oversupplied channel heading into 2026.” CFO Shane Hostetter added that, “from the Q2 and Q3 perspective, there’s probably about $65 million of aftermarket sales that . . . probably should have been allocated to more of this year.”
On this news, the price of Chemours’ shares fell $3.34 per share, or 18.63%, to close at $14.59 per share on August 5, 2026.
If you purchased securities of Chemours as above and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at (877) 515-1850 or via email (lewis.kahn@ksfcounsel.com), or fill out the form on this page.
The case is Darcy v. The Chemours Company, et al., No. 26-cv-01299.